TapImmune to Present at the Jefferies 2018 Global Healthcare Conference

JACKSONVILLE, Florida, May  31, 2018 – TapImmune Inc. (NASDAQ: TPIV), a clinical-stage immuno-oncology company, today announced that its President and CEO, Peter L. Hoang, will present at the Jefferies 2018 Global Healthcare Conference taking place June 5-8, 2018, in New York City. TapImmune Company Presentation Date: Thursday, June 7, 2018 Time: 3:30 PM ET An audio webcast will be accessible via the News and Events section of the TapImmune website: https://www.markertherapeutics.com/events. An archive of the audio will remain available for 90 days following the presentation.[/vc_column_text][vc_empty_space height=”4px”][vc_column_text][pr-disclaimer2]